Yunnan Baiyao Group Co., Ltd. at its Extraordinary General Meeting held on March 11, 2016, approved the appointment of Liu Jin as independent director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
54.51 CNY | -1.25% | -1.87% | +10.91% |
05-13 | Yunnan Baiyao's Unit to Conduct Clinical Trials on Prostate Cancer Drug | MT |
05-13 | Yunnan Baiyao to Conduct Clinical Trials on Flurbiprofen Gel Patch | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.91% | 13.43B | |
+37.74% | 723B | |
+34.26% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.13% | 244B | |
+9.69% | 208B | |
-4.79% | 205B | |
+2.81% | 168B |
- Stock Market
- Equities
- 000538 Stock
- News Yunnan Baiyao Group Co.,Ltd
- Yunnan Baiyao Group Co., Ltd. Appoints Liu Jin as Independent Director